Sequenom Announces Participation at Oppenheimer 23rd Annual Healthcare Conference

    Sequenom Announces Participation at Oppenheimer 23rd Annual Healthcare
                                  Conference

PR Newswire

SAN DIEGO, Dec. 6, 2012

SAN DIEGO, Dec. 6, 2012 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life
sciences company providing innovative diagnostic testing and genetic analysis
solutions, today announced the Company's participation at the upcoming
Oppenheimer 23^rd Annual Healthcare Conference, to be hosted at the Waldorf
Astoria in New York, NY. 

On Thursday, December 13, Ronald M. Lindsay, Ph.D., Director and EVP of
Research and Development and Paul V. Maier, Chief Financial Officer, will
present starting at 10:00 am ET to provide an overview of and update on the
Company.

The presentation is expected to last approximately 30 minutes and will be
webcast live through the "Investors" section of the Sequenom website at
www.sequenom.com. An audio replay will be available for 30 days following the
initial presentation webcast. 

About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to
improving healthcare through revolutionary genetic analysis solutions.
Sequenom develops innovative technology, products and diagnostic tests that
target and serve discovery and clinical research, and molecular diagnostics
markets. The company was founded in 1994 and is headquartered in San Diego,
California. Sequenom maintains a Web site at http://www.sequenom.com to which
Sequenom regularly posts copies of its press releases as well as additional
information about Sequenom. Interested persons can subscribe on the Sequenom
Web site to email alerts or RSS feeds that are sent automatically when
Sequenom issues press releases, files its reports with the Securities and
Exchange Commission or posts certain other information to the Web site.

(Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)

SOURCE Sequenom, Inc.

Website: http://www.sequenom.com
Contact: Marcy Graham, Senior Director, Investor Relations & Corp Comm for
Sequenom, Inc., +1-858-202-9028, mgraham@sequenom.com; Jakob Jakobsen, Media
Contact for Chandler Chicco Agency, +1-310-309-1003,
jjakobsen@chandlerchiccocompanies.com